Didattica

Insegnamenti

2023 - 2024

Ricerca

Pubblicazioni IRIS

• Comparing Outcomes Between CPX-351 and Fludarabine-Based Induction in Secondary Acute Myeloid Leukemia in the Real-World Setting: The Prognostic Role of Measurable Residual Disease
  Anno: 2025
• Establishment and characterization of a novel fibroblastic cell line (Sci13d) derived from the broncho-alveolar lavage of a patient with fibrotic hypersensitivity pneumonitis
  Anno: 2021
• A novel mutation of Twinkle in Perrault syndrome: A not rare diagnosis?
  Anno: 2020
• Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information
  Anno: 2018
• High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients
  Anno: 2016